Vaccines
In a sudden move, the U.S. Centers for Disease Control and Prevention (CDC) removed new guidelines from its website suggesting that the new coronavirus can be transmitted by tiny droplets over a distance greater than six feet. The updated guidelines, which were posted on Friday but removed on Monday,
Vaccines
Pfizer, in partnership with German biotechnology company BioNTech, aims to expand its Phase 3 clinical trial for its COVID-19 vaccine, with plans to enroll 44,000 participants and include a more diverse population. This move is seen as a step towards ensuring the vaccine's safety and efficacy in
Vaccines
Pfizer Inc and BioNTech SE have proposed to the US Food and Drug Administration (FDA) to expand their Phase 3 pivotal COVID-19 vaccine trial to approximately 44,000 participants, increasing the diversity of the trial population. The initial target of 30,000 participants is expected to be reached by next
Vaccines
Nine top pharmaceutical companies, including AstraZeneca, BioNTech, and Pfizer, have signed a joint pledge to prioritize the safety of vaccinated individuals in the development of a Covid-19 vaccine. This commitment is outlined in a four-point pledge that emphasizes adherence to high scientific and ethical standards during clinical trials and the
Vaccines
Top executives from AstraZeneca, BioNTech, GlaxoSmithKline, Johnson & Johnson, Merck, Moderna, Novavax, Pfizer, and Sanofi have signed a historic pledge to ensure the safety and well-being of individuals vaccinated against COVID-19. The commitment comes as these companies work towards potential global regulatory filings and approvals of the first COVID-19 vaccines.
Vaccines
British drugmaker AstraZeneca has kicked off Phase 3 trials of its experimental coronavirus vaccine in the United States, making it the third company to initiate late-stage trials of a vaccine aimed at preventing COVID-19. AstraZeneca's vaccine, developed in partnership with Oxford University, has received backing from the US
Vaccines
National Institutes of Health announced the initiation of a multi-site, Phase 3 clinical trial evaluating the investigational COVID-19 vaccine candidate AZD1222. The trial aims to enroll approximately 30,000 adult volunteers at 80 sites in the United States to determine if the vaccine can prevent symptomatic coronavirus disease 2019 (COVID-19)
Vaccines
Canada's hopes for having one of the earliest coronavirus vaccines available have been significantly delayed due to China's reluctance to approve the shipment of a candidate vaccine developed by CanSino Biologics, Inc. Dr. Scott Halperin, director of the Canadian Centre for Vaccinology at Dalhousie University in
Vaccines
Taiwan's Food and Drug Administration (FDA) has conditionally approved United Biomedical, Inc., Asia (UBI Asia) to start clinical trials for its coronavirus vaccine, marking the second Taiwanese-made vaccine to enter the human testing phase. This move follows Adimmune Corporation's approval to begin Phase I clinical trials
Vaccines
As COVID-19 vaccines enter critical phase 3 trials, Johnson & Johnson is gearing up for the largest study yet, aiming to enroll 60,000 participants. This massive trial will kick off next month and is set to surpass the enrollment of rival vaccine makers Moderna and Pfizer, who have already
Vaccines
In a significant development towards combating the COVID-19 pandemic, the institutional ethics committees of the Bharati Hospital and Research Centre, KEM Hospital, and other hospitals in Pune have granted approval for the conduct of clinical trials of the Oxford University's AstraZeneca COVID-19 vaccine. The trials, which aim to
Vaccines
As India pushes forward in its fight against COVID-19, the institutional ethics committees of the Bharati Hospital and Research Centre, and KEM Hospital have given a go-ahead for the clinical trials of the Oxford University's AstraZeneca Covid-19 vaccine. The trials are expected to begin soon, with the Bharati
